MyFinsight
Home
Blog
About
Contact
Download
Download image
Net
(decrease)/increase in cash, cash...
-$8,974K
Stock-based compensation
expense
$2,084K
Accrued expenses and
other current...
$763K
Accounts payable
$549K
Non-cash operating lease
expense
$477K
Depreciation and
amortization
$161K
Proceeds from maturities
of marketable...
$21,000K
something is missing
$3,869K
Net cash used in
operating activities
-$6,497K
Net cash (used
in)/provided by investing...
-$2,450K
Net cash used in
financing activities
-$27K
Canceled cashflow
$4,034K
Canceled cashflow
$21,000K
Canceled cashflow
$3,869K
Net loss
-$8,015K
Purchases of marketable
securities
$23,435K
Exercise of pre-funded
warrants in connection...
-$3,864K
Deferred revenue
-$1,708K
Operating lease
liabilities
-$477K
Net accretion and
amortization of investments...
$244K
Prepaid expenses and
other current assets
$87K
Purchases of property and
equipment
$15K
Tax withholdings
paid on behalf of...
$32K
Back
Back
Cash Flow
Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. (RANI)
source: myfinsight.com